Tongue Cancer
📧 Sign up to get email alerts when something new happens for Tongue Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
A completed clinical trial evaluating whether circulating tumor DNA can predict outcomes in patients with stage IV head and neck cancer or s…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the correlation between FAZA PET hypoxia imaging and 3D histology in oral tongue cancer; the study status is susp…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. [Phase 1, Phase 2]
Phase 1b/Phase 2 clinical trial evaluating food-based modulation of biomarkers in tissues from individuals at high risk for oral cancer has …
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer [Phase 1, Phase 2]
Phase 1/2 trial update evaluating high-activity natural killer immunotherapy for small metastases in tongue cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent tongue cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating interstitial photodynamic therapy for recurrent head and neck cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Study of Tongue Conservation Surgery for Oral Tongue Cancer [Phase 2]
Phase 2 study evaluating tongue-conservation surgery for tongue cancer has been terminated; sponsor is Taipei Veterans General Hospital, Tai…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial examining cisplatin with or without the WEE1 inhibitor MK-1775 in recurrent or metastatic head and neck cancers was terminated…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
This document reports a completed Phase 1/2 clinical trial of rapamycin therapy for head and neck squamous cell carcinoma, with results post…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [Phase 1]
Phase 1 study evaluating the combination of erlotinib hydrochloride and cetuximab in patients with advanced cancers including head and neck,…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue [Phase 2]
SWOG-9451 was a Phase 2 trial evaluating combination chemotherapy and radiotherapy for stage III/IV hypopharyngeal or tongue cancer. The stu…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab [Phase 2]
This Phase II randomized trial assessed cetuximab with sorafenib versus cetuximab alone in metastatic head and neck squamous cell carcinomas…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia [Phase 2]
Phase 2 trial evaluating Bowman-Birk inhibitor concentrate to prevent cancer in patients with oral leukoplakia. The study is completed with …
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging [NA]
This completed clinical trial evaluates whether adaptive treatment strategies guided by functional MRI and diffusion tensor imaging can impr…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer [NA]
A clinical trial update describes a study comparing different general anesthesia methods and their effects on immune responses in patients u…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating GM-CSF mouthwash to prevent and treat mucositis in patients undergoing radiation therapy for head and neck cancer; …
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a gene therapy approach to prevent progression to cancer in premalignant lesions of the lip and oral cav…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in locally recurrent or metastatic squamous cell carcinoma of the head and ne…